Assessment of the Combined Treatment with Umbelliferone and Four Classical Antiepileptic Drugs Against Maximal Electroshock-Induced Seizures in Mice

Pharmacology

Volumn 96, Issue 3-4, 2015, Pages 175-180

  Zagaja, Mirosław ^a   Andres Mach, Marta ^a   Skalicka Woźniak, Krystyna ^b   Rękas, Anna R ^c   Kondrat Wróbel, Maria W ^c   Gleńsk, Michał ^d   Łuszczki, Jarogniew J ^a,c  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c Medical University   (Poland)

^d WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

High performance counter current chromatography; Mouse maximal electroshock induced seizure model; Umbelliferone (7 hydroxycoumarin)

Indexed keywords

CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; UMBELLIFERONE; VALPROIC ACID; 7-HYDROXYCOUMARIN; ANTICONVULSIVE AGENT; UMBELLIFERONE DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; ARTICLE; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG DETERMINATION; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; ELECTROSHOCK SEIZURE; EXPERIMENTAL SEIZURE; HINDLIMB; MALE; MAXIMAL ELECTROSHOCK INDUCED SEIZURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BRAIN; COMBINATION DRUG THERAPY; DRUG INTERACTION; ELECTRIC SHOCK; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; SEIZURES;

ANIMALS; ANTICONVULSANTS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ELECTROSHOCK; INJECTIONS, INTRAPERITONEAL; MALE; MICE; SEIZURES; UMBELLIFERONES;

EID: 84939484746     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000438704     Document Type: Article

References (33)

1. Kwan P, Brodie MJ: Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314-319.
2. Kwan P, Brodie MJ: Epilepsy after the first drug fails: substitution or add-on? Seizure 2000; 9: 464-468.
3. Malawska B: New anticonvulsant agents. Curr Top Med Chem 2005; 5: 69-85.
4. Vasconcelos JF, Teixeira MM, Barbosa-Filho JM, Agra MF, Nunes XP, Giulietti AM, Ribeiro-Dos-Santos R, Soares MB: Effects of umbelliferone in a murine model of allergic airway inflammation. Eur J Pharmacol 2009; 609: 126-131.
5. Ramesh B, Pugalendi KV: Antihyperglycemic effect of umbelliferone in streptozotocin-diabetic rats. J Med Food 2006; 9: 562-566.
6. Ramesh B, Pugalendi KV: Influence of umbelliferone on glycoprotein components in diabetic rats. Toxicol Mech Methods 2007; 17: 153-159.
7. Ramesh B, Pugalendi KV: Antihyperlipidemic and antidiabetic effects of umbelliferone in streptozotocin diabetic rats. Yale J Biol Med 2005; 78: 189-196.
8. Ramesh B, Pugalendi KV: Antioxidant role of Umbelliferone in STZ-diabetic rats. Life Sci 2006; 79: 306-310.
9. Skalicka-Wo?niak K, G?owniak K: Pressurized liquid extraction of coumarins from fruits of Heracleum leskowii with application of solvents with different polarity under increasing temperature. Molecules 2012; 17: 4133-4141.
10. Barros TA, de Freitas LA, Filho JM, Nunes XP, Giulietti AM, de Souza GE, dos Santos RR, Soares MB, Villarreal CF: Antinociceptive and anti-inflammatory properties of 7-hydroxycoumarin in experimental animal models: potential therapeutic for the control of inflammatory chronic pain. J Pharm Pharmacol 2010; 62: 205-213.
11. de Lima FO, Nonato FR, Couto RD, Barbosa Filho JM, Nunes XP, Ribeiro dos Santos R, Soares MB, Villarreal CF: Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin. J Nat Prod 2011; 74: 596-602.
12. Wu L, Wang X, Xu W, Farzaneh F, Xu R: The structure and pharmacological functions of coumarins and their derivatives. Curr Med Chem 2009; 16: 4236-4260.
13. Toyama DO, Marangoni S, Diz-Filho EB, Oliveira SC, Toyama MH: Effect of umbelliferone (7-hydroxycoumarin, 7-HOC) on the enzymatic, edematogenic and necrotic activities of secretory phospholipase A2 (sPLA2) isolated from Crotalus durissus collilineatus venom. Toxicon 2009; 53: 417-426.
14. Lake BG: Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment. Food Chem Toxicol 1999; 37: 423-453.
15. Kanimozhi G, Prasad NR, Ramachandran S, Pugalendi KV: Umbelliferone modulates gamma-radiation induced reactive oxygen species generation and subsequent oxidative damage in human blood lymphocytes. Eur J Pharmacol 2011; 672: 20-29.
16. Li D, Ellis EM: Inducible protection of human astrocytoma 1321N1 cells against hydrogen peroxide and aldehyde toxicity by 7-hydroxycoumarin is associated with the upregulation of aldo-keto reductases. Neurotoxicology 2012; 33: 1368-1374.
17. Kurokawa M, Watanabe W, Shimizu T, Sawamura R, Shiraki K: Modulation of cytokine production by 7-hydroxycoumarin in vitro and its efficacy against influenza infection in mice. Antiviral Res 2010; 85: 373-380.
18. Zhao D, Islam MN, Ahn BR, Jung HA, Kim BW, Choi JS: In vitro antioxidant and antiinflammatory activities of Angelica decursiva. Arch Pharm Res 2012; 35: 179-192.
19. Islam MN, Choi RJ, Jin SE, Kim YS, Ahn BR, Zhao D, Jung HA, Choi JS: Mechanism of anti-inflammatory activity of umbelliferone 6-carboxylic acid isolated from Angelica decursiva. J Ethnopharmacol 2012; 144: 175-181.
20. Timonen JM, Nieminen RM, Sareila O, Goulas A, Moilanen LJ, Haukka M, Vainiotalo P, Moilanen E, Aulaskari PH: Synthesis and anti-inflammatory effects of a series of novel 7-hydroxycoumarin derivatives. Eur J Med Chem 2011; 46: 3845-3850.
21. Stefanova T, Nikolova N, Neychev H, Zlabinger G: Phagocytosis and killing of salmonella by 7-hydroxycoumarin activated macrophages. Immunol Invest 2012; 41: 199-213.
22. Luszczki JJ, Glowniak K, Czuczwar SJ: Timecourse and dose-response relationships of imperatorin in the mouse maximal electroshock seizure threshold model. Neurosci Res 2007; 59: 18-22.
23. Luszczki JJ, Glowniak K, Czuczwar SJ: Imperatorin enhances the protective activity of conventional antiepileptic drugs against maximal electroshock-induced seizures in mice. Eur J Pharmacol 2007; 574: 133-139.
24. Luszczki JJ, Wojda E, Raszewski G, G?owniak K, Czuczwar SJ: Influence of imperatorin on the anticonvulsant activity and acute adverseeffect profile of lamotrigine in maximal electroshock-induced seizures and chimney test in mice. Pharmacol Rep 2008; 60: 566-573.
25. ?uszczki JJ, Andres-Mach M, Gle?sk M, Skalicka-Wo?niak K: Anticonvulsant effects of four linear furanocoumarins, bergapten, imperatorin, oxypeucedanin, and xanthotoxin, in the mouse maximal electroshock-induced seizure model: A comparative study. Pharmacol Rep 2010; 62: 1231-1236.
26. Zagaja M, Pyrka D, Skalicka-Wozniak K, Glowniak K, Florek-Luszczki M, Glensk M, Luszczki JJ: Effect of xanthotoxin (8-methoxypsoralen) on the anticonvulsant activity of classical antiepileptic drugs against maximal electroshock-induced seizures in mice. Fitoterapia 2015; 105: 1-6.
27. Luszczki JJ, Andres-Mach M, Cisowski W, Mazol I, Glowniak K, Czuczwar SJ: Osthole suppresses seizures in the mouse maximal electroshock seizure model. Eur J Pharmacol 2009; 607: 107-109.
28. Löscher W, Fassbender CP, Nolting B: The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res 1991; 8: 79-94.
29. Kielbus M, Skalicka-Wozniak K, Grabarska A, Jeleniewicz W, Dmoszynska-Graniczka M, Marston A, Polberg K, Gawda P, Klatka J, Stepulak A: 7-Substituted coumarins inhibit proliferation and migration of laryngeal cancer cells in vitro. Anticancer Res 2013; 33: 4347-4356.
30. Luszczki JJ, Ratnaraj N, Patsalos PN, Czuczwar SJ: Isobolographic analysis of interactions between loreclezole and conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Naunyn Schmiedebergs Arch Pharmacol 2006; 373: 169-181.
31. Litchfield JT Jr, Wilcoxon F: A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949; 96: 99-113.
32. Luszczki JJ, Wojda E, Andres-Mach M, Cisowski W, Glensk M, Glowniak K, Czuczwar SJ: Anticonvulsant and acute neurotoxic effects of imperatorin, osthole and valproate in the maximal electroshock seizure and chimney tests in mice: A comparative study. Epilepsy Res 2009; 85: 293-299.
33. Luszczki JJ, Danysz W, Czuczwar SJ: Interactions of MRZ 2/576 with felbamate, lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model. Pharmacology 2008; 81: 259-265.